673208 |
ONCOTARGETS AND THERAPY |
XBP1s Acts as a Tumor Suppressor to Inhibit the EMT Process and Metastasis of Papillary Thyroid Cancer |
2021-04-01 |
10.2147/ott.s297046 |
Yang Wen, Xu Xia, Xu Ming, Zhou Jun, Xi Zihan, Guo Hui, Ming Jie, Huang Tao |
673207 |
ONCOTARGETS AND THERAPY |
LHX6 Affects Erlotinib Resistance and Migration of EGFR-Mutant Non-Small-Cell Lung Cancer HCC827 Cells Through Suppressing Wnt/β-Catenin Signaling [Corrigendum] |
2021-04-01 |
10.2147/ott.s313313 |
Wang Qiang, Liao Jinrong, He Zhiyong, Su Ying, Lin Dong, Xu Ling, Xu Haipeng, Lin Jinghui |
673206 |
ONCOTARGETS AND THERAPY |
Evaluation of the UK Myeloma Research Alliance Risk Profile in Chinese Patients with Newly Diagnosed Multiple Myeloma without Autologous Stem Cell Transplantation |
2021-04-01 |
10.2147/ott.s300834 |
Ma Kewa, Ye Jiannan, Wang Lingling, Sun Chao, Zhou Xin |
673205 |
ONCOTARGETS AND THERAPY |
Construction of miRNA-mRNA Regulatory Network and Prognostic Signature in Endometrial Cancer |
2021-04-01 |
10.2147/ott.s272222 |
Sun Rui, Liu Jinhui, Nie Sipei, Li Siyue, Yang Jing, Jiang Yi, Cheng Wenjun |
673204 |
ONCOTARGETS AND THERAPY |
Calycosin Induces Gastric Cancer Cell Apoptosis via the ROS-Mediated MAPK/STAT3/NF-κB Pathway |
2021-04-01 |
10.2147/ott.s292388 |
Zhang Yu, Zhang Jian-Qiang, Zhang Tong, Xue Hui, Zuo Wen-Bo, Li Yan-Nan, Zhao Yue, Sun Geng, Fu Zhong-Ren, Zhang Qing, Zhao Xue, Teng Yue, Wang An-Qi, Li Jia-Zhu, Wang Ying, Jin Cheng-Hao |
673203 |
ONCOTARGETS AND THERAPY |
Hodgkin Lymphoma as a Secondary Neoplasm During Therapy for Chronic Myeloid Leukaemia: Case Report and Review of the Literature |
2021-04-01 |
10.2147/ott.s300320 |
Paczkowska Edyta, Janowski Michał, Karpińska Katarzyna, Ryłów Małgorzata, Zdziarska Barbara, Poncyljusz Wojciech, Machaliński Bogusław |
673202 |
ONCOTARGETS AND THERAPY |
Actin-Like Protein 8 Promotes the Progression of Triple-Negative Breast Cancer via Activating PI3K/AKT/mTOR Pathway |
2021-04-01 |
10.2147/ott.s291403 |
Fan Shaoxia, Yan Shen, Yang Yang, Shang Jian, Hao Min |
673201 |
ONCOTARGETS AND THERAPY |
Circ_0006168 Promotes the Migration, Invasion and Proliferation of Esophageal Squamous Cell Carcinoma Cells via miR-516b-5p-Dependent Regulation of XBP1 |
2021-04-01 |
10.2147/ott.s293180 |
Huang Yunhe, Jiang Lei, Wei Guangxia |
673200 |
ONCOTARGETS AND THERAPY |
Lipid–Polymer Hybrid Nanoparticle-Based Combination Treatment with Cisplatin and EGFR/HER2 Receptor-Targeting Afatinib to Enhance the Treatment of Nasopharyngeal Carcinoma |
2021-04-01 |
10.2147/ott.s286813 |
Fu Dehui, Li Chao, Huang Yongwang |
673199 |
ONCOTARGETS AND THERAPY |
Integrated Profiling Identifies CCNA2 as a Potential Biomarker of Immunotherapy in Breast Cancer |
2021-04-01 |
10.2147/ott.s296373 |
Wang Yichao, Zhong Qianyi, Li Zhaoyun, Lin Zhu, Chen Hanjun, Wang Pan |